Literature DB >> 25270494

Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness.

Allison G Robertson, Jeffrey W Swanson, Richard A Van Dorn, Marvin S Swartz.   

Abstract

Little empirical research has directly examined the extent to which early and consistent participation in outpatient services and adherence to prescribed psychotropic medications after a psychiatric hospitalization can help people with serious mental illnesses avoid arrest and incarceration and what impact this might have on state and local costs. The authors examined effects of medication adherence in the first 90 days after a psychiatric hospitalization among 1,367 adults with schizophrenia or bipolar disorder served by the public behavioral health systems of Miami-Dade County and Pinellas County in Florida. Better adherence was associated with lower subsequent criminal justice costs and greater use of treatment services. A modest investment in promoting treatment participation and medication adherence may reduce criminal justice involvement and costs for persons with serious mental illness.

Entities:  

Mesh:

Year:  2014        PMID: 25270494     DOI: 10.1176/appi.ps.201400247

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  12 in total

Review 1.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

2.  Does Non-Adherence Increase Treatment Costs in Schizophrenia?

Authors:  Mark Pennington; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

Review 3.  The Cost of Relapse in Schizophrenia.

Authors:  Mark Pennington; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

4.  Combining Medication Adherence Support Plus Long-Acting Injectable Antipsychotic Medication: A Post-Hoc Analysis of 3 Pilot Studies.

Authors:  Thomas Canales; Samuel Rodman; Danette Conklin; Kaylee Sarna; Martha Sajatovic; Jennifer B Levin
Journal:  Psychopharmacol Bull       Date:  2022-06-27

5.  Behavioral Crisis and First Response: Qualitative Interviews with Chicago Stakeholders.

Authors:  Conor H Murray; Juan L Contreras; Caroline H Kelly; Deborah K Padgett; Harold A Pollack
Journal:  Community Ment Health J       Date:  2022-06-25

6.  Validity of police contacts as a performance indicator for the public mental health care system in Amsterdam: an open cohort study.

Authors:  S Lauriks; M C A Buster; M A S de Wit; O A Arah; A W Hoogendoorn; J Peen; N S Klazinga
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-02-15       Impact factor: 4.328

7.  Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness.

Authors:  Allison G Robertson; Michele M Easter; Hsiu-Ju Lin; Linda K Frisman; Jeffrey W Swanson; Marvin S Swartz
Journal:  J Subst Abuse Treat       Date:  2017-12-12

8.  Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.

Authors:  Allison G Robertson; Michele M Easter; HsiuJu Lin; Linda K Frisman; Jeffrey W Swanson; Marvin S Swartz
Journal:  Am J Psychiatry       Date:  2018-07-01       Impact factor: 18.112

9.  Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters.

Authors:  Madhav P Bhatta; Saroj Bista; Antoine C El Khoury; Eric G Hutzell; Neeta Tandon; Douglas Smith
Journal:  J Health Econ Outcomes Res       Date:  2021-05-19

Review 10.  Economic impact of medication non-adherence by disease groups: a systematic review.

Authors:  Rachelle Louise Cutler; Fernando Fernandez-Llimos; Michael Frommer; Charlie Benrimoj; Victoria Garcia-Cardenas
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.